Our Commitment to Patients
Spectrum's core mission is to bring pharmaceutical products to patients for unmet medical needs. To this mission, we bring our years of drug development expertise, coupled with the insight of working in many different oncology indications. Learn more >
Spectrum and its subsidiaries have five marketed oncology/hematology products, three for different types of non-Hodgkins lymphoma, one for advanced metastatic colorectal cancer, and one for a certain type of acute lymphoblastic leukemia (ALL). There are two products in late-stage development, as well as a broad and diversified portfolio of proprietary drugs in various stages of development, all with a focus on oncology and hematology. Learn more >
Expanding Patient Options
Our passion to deliver additional options for patients suffering from cancer is behind every action we take.
Watch Spectrum open the NASDAQ Opening bell ceremony in November 2011
We will work to understand their needs and develop new and innovative therapies that offer hope for improved disease outcomes. Learn more about the Spectrum philosophy.